fosamprenavir has been researched along with raltegravir potassium in 2 studies
Studies (fosamprenavir) | Trials (fosamprenavir) | Recent Studies (post-2010) (fosamprenavir) | Studies (raltegravir potassium) | Trials (raltegravir potassium) | Recent Studies (post-2010) (raltegravir potassium) |
---|---|---|---|---|---|
174 | 55 | 37 | 1,238 | 243 | 879 |
Protein | Taxonomy | fosamprenavir (IC50) | raltegravir potassium (IC50) |
---|---|---|---|
Translocator protein | Rattus norvegicus (Norway rat) | 0.13 | |
Integrase | Human immunodeficiency virus 1 | 0.0494 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sax, PE | 1 |
Degli Antoni, A; Ferrari, C; Fragola, V; Manfredi, R; Weimer, LE | 1 |
2 other study(ies) available for fosamprenavir and raltegravir potassium
Article | Year |
---|---|
Meeting report. Report from ICAAC.
Topics: Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Carbamates; Cyclopropanes; Furans; HIV Infections; Humans; Oligopeptides; Organic Chemicals; Organophosphates; Oxazines; Patient Compliance; Pyridines; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Sulfonamides; Viral Load | 2006 |
A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probab
Topics: Adult; Carbamates; Cardiomyopathies; Chemical and Drug Induced Liver Injury; Creatine Kinase; Cyclohexanes; Drug Substitution; Drug Therapy, Combination; Fatty Liver; Furans; Hepatitis C, Chronic; HIV Fusion Inhibitors; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Liver Cirrhosis; Male; Maraviroc; Organophosphates; Pyrrolidinones; Raltegravir Potassium; Sulfonamides; Triazoles | 2012 |